Healthcare Compliance Training

After nearly two decades in litigation, the High Court of Kenya has issued a powerful and precedent-setting judgment in the case of Naila Qureshi & Another v Dr. Raffique Parker & 2 Others (CC 610 of 2007)—a case that interrogates the essence of informed consent, professional duty, and institutional accountability in medical practice. What Happened? The 1st Plaintiff, a patient at a top Nairobi hospital, underwent what was supposed to be a standard hysterectomy. Unbeknownst to her, her cervix was removed without her knowledge or consent, and she later developed a vesico-vaginal fistula due to alleged surgical negligence. This left her with lifelong urinary incontinence, emotional trauma, sexual dysfunction, and loss of dignity. After exhausting options locally, she sought treatment in South Africa, at a staggering cost. THE RESULT? The Court found all three Defendants, two doctors and the hospital, jointly and severally liable, citing breach of medical duty, lack of informed consent, and negligent post-operative care. TOTAL AWARD: ➡️ Kshs. 157,207,524.20 in general damages, special damages, future medical expenses, and loss of earning capacity ➡️ Plus costs of the suit and interest 📌 KEY LEGAL & PRACTICAL TAKEAWAYS: 1. Informed Consent is a Legal Right Signing a form is not enough. Patients must understand the procedure, risks, and alternatives. Silence or ambiguity can be costly, ethically and legally. 2. Multidisciplinary Care is Non-Negotiable Complex conditions like endometriosis must be handled by coordinated teams (gynecologists, urologists, etc.). Solo judgment in specialised areas is a recipe for liability. 3. Hospitals Must Take Responsibility Even where doctors are not employees, hospitals have a duty to vet, supervise, and ensure proper facilities, equipment, and patient care protocols. The Law is Evolving This case sets a strong precedent: Patient dignity, bodily autonomy, and spousal rights matter. Negligence, even in private care settings, can carry massive financial and reputational risk. To all healthcare providers: review your consent processes, documentation practices, and specialist referral systems. To patients: know your rights. Never be afraid to ask questions or seek a second opinion.

🚀 Essential Clinical Trial Documents – Part 3: Informed Consent Form (ICF) & Patient Information Sheet (PIS) ✍️🏥 In clinical trials, the Informed Consent Form (ICF) is one of the most critical documents, ensuring that the participant’s rights, safety, and well-being are protected. 🔹 What is an ICF? An ICF is a document that provides clear, detailed information about the clinical trial to potential participants. It allows them to make a voluntary and informed decision about whether they wish to participate. 🔹 Key Contents of an ICF: ✅ Purpose of the clinical trial ✅ Description of the study drug/device/intervention ✅ Procedures involved and duration of participation ✅ Potential risks and discomforts ✅ Possible benefits (if any) ✅ Alternative treatments available ✅ Confidentiality of participant data ✅ Right to withdraw at any time without penalty ✅ Contact information for queries and emergencies 🔹 Patient Information Sheet (PIS): The PIS is often attached to the ICF and explains trial details in simpler, more patient-friendly language to help participants better understand the study. 🔹 Important to Note: • The ICF must be approved by an Ethics Committee before use. ✔️ • Participants must be given sufficient time to review and ask questions before signing. • Consent is not a one-time event — participants can withdraw at any stage! • Any updates to the study must be reflected through re-consenting with updated ICFs. In short: The ICF is not just paperwork — it’s about respect, transparency, and empowering patients to make informed decisions. 🔖 Save this post for future reference! #ClinicalTrials #ClinicalResearch #InformedConsent #Ethics #PatientCentricity #EssentialDocumentsSeries #GCP #PatientSafety

A signature is not consent. A conversation is. A recent court order held that a signed pre-printed consent form did not amount to valid informed consent. The judgment wasn't about whether the surgery was performed correctly. It focused on whether the patient was adequately informed of the procedure, alternatives, and material risks. This creates a real challenge for high-volume hospitals. Is a generic printed form enough? Is handwritten documentation practical? Or do we need procedure-specific, digital, or even video-assisted consent systems? The debate is no longer about paperwork. It's about proving that understanding occurred. What should constitute legally defensible informed consent in modern Indian healthcare? Patient safety is not a protocol. It is a mindset. What Have Indian Courts Said Earlier? Samira Kohli vs Dr. Prabha Manchanda (Supreme Court, 2008) The landmark judgment. The Supreme Court held that consent is valid only when the patient is given adequate information regarding: • Nature and purpose of treatment • Benefits expected • Material risks • Alternatives available Blanket or generic consent is insufficient. This remains the foundation of informed consent law in India. Montgomery Principle (UK Supreme Court, 2015) Though not Indian law, it has influenced global thinking. The standard shifted from: "What would a reasonable doctor disclose?" to "What would a reasonable patient want to know?" The focus became patient autonomy. #PatientSafety #InformedConsent #MedicalLaw #Anaesthesia #Surgery #RiskManagement #ClinicalGovernance #HealthcareLeadership #OTSafety #vitaguard

In Clinical Research, everything is changing right now. And no one is noticing it. Implementing ICH E6(R3) is not just a regulatory update - it’s a mindset shift. I recently supported a client in reworking their entire SOP framework to reflect a risk-based approach across all functional areas. The real challenge? Turning abstract requirements into concrete, day-to-day practices. Together, we identified critical aspects, prioritized real risks, and introduced more flexibility by replacing traditional oversight with tailored, data-driven processes. Through collaborative training sessions, the teams didn’t just follow the new SOPs — they understood them. The result? A culture shift. Risk awareness became part of how decisions are made, not just a checkbox. ICH E6(R3) only works when people live it - not when it just sits in a binder. I thought to myself that it's time for a professional update, and a resource that could make a real difference for anyone working in clinical research, especially in Clinical Operations and GCP Compliance. 📘“Regulatory Shifts: Adapting to Changes in Good Clinical Practice” 📖 ❓What’s inside? A comprehensive overview of how Good Clinical Practice (GCP) is evolving – including the latest on ICH E6(R3), risk-based monitoring, digital tools, patient-centric approaches, and even AI and data analytics. You’ll find practical strategies, case studies, and actionable steps for integrating these changes into your daily work. ❓Who is it for? - Clinical Operations Professionals - QA and Compliance Teams - Clinical Trial Leads, Monitors, GCP officers … anyone involved in clinical trials who wants to stay ahead of regulatory changes. ❓Why am I sharing this? Because many teams still struggle with questions like: ➡What does ICH E6(R3) mean in practice? ➡How do we implement risk-based oversight effectively? ➡What needs to be considered with remote monitoring and eConsent? That’s why I created more than just an eBook. I’ve also launched a complete GCP Refresher Course, including certification. ❓What you’ll gain: ➡Clear explanations of the latest GCP updates ➡Real-world case studies and application guidance ➡Certification upon completion ➡Bonus: Access to our Clinical Excellence Community ❓Want to get the eBook and course info? 1. Like this post 2. Comment with “GCP-EVOLUTION” 3. Connect with me 4. I’ll send you the ebook and a practical checklist. This knowledge will help you implement Risk-based Sponsor Oversight, ensure Patient Safety and Data Integrity, and avoid Inspection Findings, all based on the latest GCP guidelines. Let’s raise the standard for clinical research. – Jessica

𝐈'𝐯𝐞 𝐚𝐮𝐝𝐢𝐭𝐞𝐝 𝟏𝟎𝟎+ 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥 𝐬𝐢𝐭𝐞𝐬. 𝐎𝐧𝐞 𝐝𝐨𝐜𝐮𝐦𝐞𝐧𝐭 𝐩𝐫𝐞𝐝𝐢𝐜𝐭𝐬 𝐰𝐡𝐞𝐭𝐡𝐞𝐫 𝐲𝐨𝐮'𝐥𝐥 𝐩𝐚𝐬𝐬. It's not the one you think. Most sites assume I'm going to say the regulatory binder. Or the informed consent forms. Or the monitoring visit log. Those matter. But they're not what I look at first. Early in my career I noticed a pattern. I'd walk into a site with a pristine trial master file, every tab color-coded, every signature dated. And within two hours I'd find three findings. Then I'd walk into a site where the binders looked like they'd survived a flood, and I'd leave with zero. It happened enough times that I started tracking it. After about 60 audits I pulled my notes and looked for the variable. It wasn't the filing system. It wasn't the experience level of the PI. It wasn't even the CRO. It was the training log. Not whether training had been completed. Every site checks that box. What separated the zero-finding sites was how the training log answered one question: does this person know what to do when something goes wrong? The sites that passed had training entries that read like decision trees. "Coordinator trained on protocol deviation reporting, including scenarios for missed visit windows, out-of-range labs, and early termination procedures. Trainer documented three case-based exercises with coordinator responses." The sites that failed had entries that read like attendance sheets. "Staff attended GCP training on 03/15. Duration: 2 hours. Signature on file." One log proves your team can think. The other proves they were in the room. When an inspector finds a deviation, the first thing they check is whether the person involved was trained on that specific scenario. If your training log says "completed GCP refresher" and the finding involves a re-consent trigger, the inspector now has two findings: the original deviation and a training gap. The log that was supposed to protect you just doubled your exposure. I audited a site last year where a coordinator handled a complex protocol amendment flawlessly. The participant needed re-consent, the source documentation captured the rationale, and the deviation report was filed within 24 hours. When I asked how she knew exactly what to do, she pulled up her training record. It showed a tabletop exercise from three months earlier that walked through that exact scenario. That's not compliance. That's readiness. After 16 years and 100+ sites, the difference between a site that survives an inspection and a site that passes one is not more documentation. It's documentation that proves your team was trained to think, not just trained to sign. 𝐏𝐮𝐥𝐥 𝐲𝐨𝐮𝐫 𝐭𝐫𝐚𝐢𝐧𝐢𝐧𝐠 𝐥𝐨𝐠 𝐫𝐢𝐠𝐡𝐭 𝐧𝐨𝐰. 𝐃𝐨𝐞𝐬 𝐢𝐭 𝐩𝐫𝐨𝐯𝐞 𝐚𝐭𝐭𝐞𝐧𝐝𝐚𝐧𝐜𝐞, 𝐨𝐫 𝐝𝐨𝐞𝐬 𝐢𝐭 𝐩𝐫𝐨𝐯𝐞 𝐫𝐞𝐚𝐝𝐢𝐧𝐞𝐬𝐬?

Compliance Wednesday: More than 75 years after the Nuremberg Code established voluntary informed consent as a foundational principle of human subjects research, FDA is still issuing Warning Letters for failures involving basic consent requirements. Through the Center for Drug Evaluation and Research, FDA cited a Clinical Investigator after a study participant underwent an optional aqueous humor collection procedure even though the participant had previously declined consent for the procedure. FDA noted that the procedure was performed despite documented refusal and cited the investigator for failing to obtain legally effective informed consent. What makes this case particularly concerning is that this was not a paperwork issue. The subject's decision was documented. The subject's refusal was known. Yet the procedure was still performed. In clinical research, using residual samples obtained during routine medical care can be an acceptable and well-understood practice when supported by appropriate consent and protocol requirements. But collecting fluid from a participant's eye is an invasive procedure that introduces additional risk. Performing that procedure after a participant explicitly declined it is not simply a process failure. It represents a breakdown of one of the most fundamental commitments we make to research participants: that their choices will be respected. FDA also challenged the site's corrective actions, noting that proposed tracking tools and labels alone did not demonstrate how investigator oversight, implementation, and staff training would prevent recurrence. Key Compliance Lessons ✅ Informed consent is an ongoing obligation, not a signed document. ✅ Optional procedures require the same level of control and oversight as primary study procedures. ✅ Documenting a participant's decision is only half the battle. Quality systems must ensure that decision is translated into operational controls. ✅ When participant choices are not respected, the issue moves beyond compliance and directly impacts subject rights, safety, and welfare. Bottom line: The most striking part of this Warning Letter is that the site had the information it needed to do the right thing. The failure wasn't the absence of consent documentation. The failure was the inability of the quality system to ensure that a participant's clearly stated decision was honored. Seventy-five years after Nuremberg, that remains a lesson worth repeating. #FDA #ComplianceWednesday #GCP #ClinicalResearch #InformedConsent #WarningLetter #ClinicalTrials #ResearchEthics #QualityAssurance #HumanSubjectProtection https://lnkd.in/eHjJbmMc

🚨 A nurse once told me: “I documented ‘patient refused.’ That’s it. I thought I was covered.” She wasn’t. That three-word note cost her 6 hours in a deposition - because it proved nothing about capacity, education, or informed decision-making. Here’s what many nurses were never taught: Refusal ≠ Documentation complete. There’s a critical difference between capacity and consent - and if your chart doesn’t show BOTH, you’re exposed. Capacity = Can this patient actually understand the decision RIGHT NOW? Consent = Did they voluntarily agree or refuse AFTER proper education? One changes hour by hour. The other requires proof of understanding. The legally defensible note looks like this: “0830 - Patient refused morning insulin. Education provided on purpose and risks (hyperglycemia, complications). Patient alert and oriented ×3, verbalized understanding, stating, ‘I don’t want it today, I feel fine.’ Provider notified (Dr. Patel) at 0840. Will monitor and re-offer at next scheduled dose.” That note covers: ✅ Capacity assessed ✅ Education documented ✅ Patient’s exact words quoted ✅ Provider notified (with time + name) ✅ Follow-up plan stated Refusals are one of the most litigated areas in nursing. Your chart is your defense. Make it one. ________________________________________ Click the link below to join our documentation community and get full access to trainings, tools, and live support. https://lnkd.in/gctBakxp See you inside. Comfort 💚

The monitor walked into our site and found 3 GCP violations in 10 minutes. My stomach dropped. Not because we were careless. But because we thought we were compliant. Here's what I learned that day: Good intentions aren't enough in clinical research. You need systems. After 10+ years in this industry, I've seen the same violations destroy careers and compromise trials. Let me break down the 7 most common GCP violations—and how to avoid them: 1️⃣ Inadequate Informed Consent ↳ The risk: Invalid subject data & regulatory penalties ✅ The fix: Always use the latest IRB-approved form & document consent properly 2️⃣ Protocol Deviations ↳ The risk: Compromised data integrity ✅ The fix: Train staff thoroughly & document all deviations immediately 3️⃣ Incomplete Source Documentation ↳ The risk: Audit findings & data loss ✅ The fix: Record data in real-time & maintain source-to-CRF consistency 4️⃣ Poor Investigational Product (IP) Accountability ↳ The risk: Patient safety issues & protocol noncompliance ✅ The fix: Log all IP receipts, dispensation, and returns accurately 5️⃣ Failure to Report Adverse Events (AEs) ↳ The risk: Regulatory noncompliance & patient risk ✅ The fix: Train team on AE reporting timelines and definitions 6️⃣ Inadequate Delegation of Duties ↳ The risk: Tasks performed by unqualified staff ✅ The fix: Maintain a current Delegation Log & verify credentials 7️⃣ Missing or Expired Regulatory Documents ↳ The risk: Site noncompliance ✅ The fix: Set calendar reminders & use a document tracker The truth is These violations aren't about being perfect. They're about being prepared. Every single one is preventable with the right systems and training. But here's what most sites miss: ➡️ Preventing GCP violations starts with training, checklists, and a compliance-first culture. Not fear. Not perfection. Just consistency. If you're running trials without these systems—you're not protecting patients. You're hoping nothing goes wrong. And hope isn't a compliance strategy. What's the most common GCP violation you've seen at sites? Drop it below. Let's learn from each other. Follow Rudy for more real-world clinical research insights. #clinicalresearch #GCP #compliance #clinicaltrials #patientSafety #regulatoryaffairs #CRA #CRC

Behavioral health providers: pay attention to what HHS released yesterday HHS issued a Dear Colleague letter on psychiatric prescribing — signed by CMS, FDA, NIH, and SAMHSA. A Dear Colleague letter isn't regulation. But these letters reliably precede coverage criteria changes, audit focus areas, and enforcement. They are a directional indicator, letting healthcare providers know where federal agencies are headed. In this case, HHS just told behavioral health providers they'll be expected to: - Document informed consent for psychiatric medications — at initiation and throughout care - Record the clinical rationale for keeping patients on psychiatric meds - Show that nonmedication alternatives were considered It's unlikely that this initiative will fade quietly to the background. Scrutiny of psychiatric prescribing — SSRIs, antipsychotics, stimulants, and mood stabilizers, especially in children — is a founding tenet of the MAHA movement. RFK Jr. has championed this since Day One. It has cross-agency coordination, and political momentum. So what do behavioral health providers do now? 1. Audit your informed consent documentation — is it captured at initiation and revisited over time? 2. Make sure clinical notes reflect *why* a patient remains on a psychiatric medication. Medical necessity documentation will be more important than ever. 3. Document when nonmedication approaches were considered or tried. This care is almost certainly being delivered. The question is whether the documentation reflects it. At Brellium, we help behavioral health providers update their documentation systems every day to respond to new regulatory and payer requirements. Happy to connect if you're thinking through how to get ahead of this.

A 100% completed training matrix may be evidence of NON-COMPLIANCE. Ok, by now you think that I have really lost the proverbail plot, but hear me out. This is a quote from a recennt CQC report. Let's disect it. In this case the staff team HAD completed training in these subject areas and the training matrix was all nicley 100% compliant, happy days. But, the training was not implemented into practice, so either one of or all of these things is defective. 1- the training 2- the process of embedding the training into practice 3- the staff team members 4- the managment oversight 5- the governace systems It's probably a combination of all of the above. So, how can care providers avoid these inadequacies? ▶️ To make sure training isn’t just a tick-box exercise, link it directly to daily practice. Be extra wary if the training is some generic online clickety mousy poop. ▶️After training, observe staff in action and give feedback so skills are embedded, not forgotten. ▶️Encourage reflective practice in supervisions and team meetings, where staff can talk through real scenarios and how training guided their decisions. ▶️Keep policies up to date with training content and involve staff in reviewing them so the guidance feels practical, not abstract. ▶️Use audits, incident reviews, and feedback from people using the service to measure whether training is being applied, and act quickly on any gaps. ▶️Create a culture that rewards the application of training, not just attendance, by recognising and celebrating staff who model best practice. Sounds like a lot of hard work, doesn't it. But, it's so worth it as effecrive training enhances care provision and avoids INADEQUATE ratings.